Top Institutions in Ophthalmology - Retinal Diseases
Leading academic medical centers with strong ophthalmology and retinal disease research programs typically conduct randomized controlled trials and have expertise in clinical pharmacology of anti-VEGF agents like aflibercept. These institutions often have dedicated retinal research units and participate in multicenter international trials.
-
#1
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a world leader in retinal disease research and clinical trials, with extensive experience in anti-VEGF therapies and retinal vein occlusion management.
-
#2
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is consistently ranked as a top ophthalmology center with a strong focus on retinal vascular diseases and has contributed significantly to clinical trials involving aflibercept and other retinal therapies.
-
#3
Wills Eye Hospital
Philadelphia, PA
Wills Eye Hospital has a renowned retina service and a strong history of participation in pivotal clinical trials for retinal vein occlusion and anti-VEGF agents.
-
#4
Moorfields Eye Hospital
London, N/A
Moorfields is a leading UK center for retinal disease research and clinical trials, with expertise in anti-VEGF therapies and retinal vein occlusion management.
-
#5
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is a premier ophthalmology center with significant contributions to retinal disease research and clinical trials involving anti-VEGF agents.